Camilo Jimenez

9PUBLICATIONS
11CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Neurosciences not elsewhere classifiedRadiation therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 10, 2026
Belzutifan, A Hypoxia-Inducible Factor 2-Alpha Inhibitor, for Patients with Advanced Pheochromocytoma and Paraganglioma.

|Jul 13, 2026
Gemcitabine and oxaliplatin combination in patients with advanced adrenocortical carcinoma.

|Apr 23, 2026
Approach to the patient with metastatic pheochromocytoma and paraganglioma: advances in systemic therapy.

|Nov 17, 2025
Metastatic neuroendocrine neoplasms of the breast: a systematic review.

Paola Jiménez, Jose Urrego, Javier Ortiz-Llinás

|May 22, 2024
Venous thromboembolism in adrenocortical carcinoma: a retrospective analysis.

Marta Laganà, Vania Balderrama-Brondani, Kelsey Ruth Herrera

|Dec 06, 2022
Biomarker response to high-specific-activity I-131 meta-iodobenzylguanidine in pheochromocytoma/paraganglioma.

Camilo Jimenez, Bennett B Chin, Richard B Noto

Pageof 2

Frequent Collaborators

3 joint publications

Steven G Waguespack

2 joint publications

Vania Balderrama-Brondani

1 joint publications

Patricia L M Dahia

1 joint publications

Alejandro Roman Gonzalez